ARTICLE | Editor's Commentary
By pursuing a personal agenda, Tidmarsh risks losing public trust: A Perspective
Recent statements and actions by the CDER director have confused drug sponsors, demoralized staff
September 30, 2025 11:14 PM UTC
George Tidmarsh, director of FDA’s Center for Drug Evaluation and Research, argues FDA should be run like a biotech company, but a biotech CEO who puts personal agendas ahead of corporate interests wouldn’t last long.
Under previous administrations, a CDER director who behaved as Tidmarsh has would have been ordered to pack up and leave. ...